心脏病女性妊娠结局:ESC ROPAC注册研究10年趋势演变
该研究基于ESC ROPAC注册研究2007至2018年前瞻性纳入5739例心脏病妊娠女性,旨在明确当代诊断特异性妊娠结局。主要结局为母体死亡或心力衰竭,总体死亡率为0.6%,肺动脉高压组最高达9%,心力衰竭发生率为11%。高危妊娠比例从2007至2010年的0.7%增至2015至2018年的10.9%,但并发症率自2010年的13.2%降至2017年的9.3%。
要点
- 心脏病妊娠女性总体死亡率为0.6%,肺动脉高压组死亡率最高达9%。
- 高危妊娠(mWHO IV级)比例从0.7%增至10.9%,但并发症率反呈下降趋势。
- 母体并发症决定因素包括孕前心衰或NYHA>II级、LVEF<40%、mWHO 4级及抗凝药使用。
核心结论
- 心脏病女性妊娠的母体死亡或心力衰竭发生率较高,但自2010年起尽管高危妊娠纳入增多,并发症率仍呈下降趋势。
- 肺动脉高压组并发症率最高,死亡率为9%。
研究设计与样本
- 前瞻性注册研究(ROPAC),2007至2018年纳入5739例心脏病妊娠女性,平均年龄29.5岁。
- 主要诊断为先天性心脏病(57%)和瓣膜性心脏病(29%)。
主要发现
- 总体死亡率为0.6%,肺动脉高压组死亡率最高为9%。
- 心力衰竭发生率为11%,心律失常为2%。
- 剖宫产分娩占44%,产科并发症发生率为17%,胎儿并发症发生率为21%。
- 高危妊娠(mWHO IV级)比例从2007至2010年的0.7%增至2015至2018年的10.9%。
- 并发症率从2010年的13.2%降至2017年的9.3%。
关键数值与推荐
- 母体并发症决定因素包括孕前心力衰竭或NYHA>II级、系统射血分数<40%、mWHO 4级及抗凝药使用。
临床怎么用
- 对心脏病妊娠女性应识别母体并发症决定因素(孕前心衰、NYHA>II级、LVEF<40%、mWHO 4级、抗凝药使用)以进行风险分层。
- 肺动脉高压女性妊娠死亡风险最高,需重点管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Reducing maternal mortality is a World Health Organization (WHO) global health goal. Although maternal deaths due to haemorrhage and infection are declining, those related to heart disease are increasing and are now the most important cause in western countries. The aim is to define contemporary diagnosis-specific outcomes in pregnant women with heart disease. METHODS AND RESULTS: From 2007 to 2018, pregnant women with heart disease were prospectively enrolled in the Registry Of Pregnancy And Cardiac disease (ROPAC). Primary outcome was maternal mortality or heart failure, secondary outcomes were other cardiac, obstetric, and foetal complications. We enrolled 5739 pregnancies; the mean age was 29.5. Prevalent diagnoses were congenital (57%) and valvular heart disease (29%). Mortality (overall 0.6%) was highest in the pulmonary arterial hypertension (PAH) group (9%). Heart failure occurred in 11%, arrhythmias in 2%. Delivery was by Caesarean section in 44%. Obstetric and foetal complications occurred in 17% and 21%, respectively. The number of high-risk pregnancies (mWHO Class IV) increased from 0.7% in 2007-2010 to 10.9% in 2015-2018. Determinants for maternal complications were pre-pregnancy heart failure or New York Heart Association >II, systemic ejection fraction <40%, mWHO Class 4, and anticoagulants use. After an increase from 2007 to 2009, complication rates fell from 13.2% in 2010 to 9.3% in 2017. CONCLUSION: Rates of maternal mortality or heart failure were high in women with heart disease. However, from 2010, these rates declined despite the inclusion of more high-risk pregnancies. Highest complication rates occurred in women with PAH.
引用
- Roos-Hesselink J, Baris L, Johnson M, et al. Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC). Eur Heart J. 2019. PMID: 30907409. doi:10.1093/eurheartj/ehz136
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。